TMCO3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.480000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.081000E-01
Normal-vs-Stage2
5.814800E-01
Normal-vs-Stage3
4.580000E-01
Normal-vs-Stage4
6.199400E-01
Stage1-vs-Stage2
1.660380E-01
Stage1-vs-Stage3
3.013900E-02
Stage1-vs-Stage4
3.141600E-01
Stage2-vs-Stage3
1.280220E-01
Stage2-vs-Stage4
9.999400E-01
Stage3-vs-Stage4
1.310220E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.690000E-01
Normal-vs-AfricanAmerican
4.400800E-01
Normal-vs-Asian
8.649400E-01
Caucasian-vs-AfricanAmerican
4.589200E-01
Caucasian-vs-Asian
4.571400E-01
AfricanAmerican-vs-Asian
3.069600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.625800E-01
Normal-vs-Female
5.398800E-01
Male-vs-Female
9.159400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.269800E-01
Normal-vs-Age(41-60Yrs)
3.879000E-01
Normal-vs-Age(61-80Yrs)
6.458800E-01
Normal-vs-Age(81-100Yrs)
7.640400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.203600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.037800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.153800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.897980E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.424200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.716400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.471400E-01
Normal-vs-Daily Drinker
6.491200E-01
Normal-vs-Weekly Drinker
9.192600E-01
Normal-vs-Occasional Drinker
1.951580E-01
Normal-vs-Social Drinker
5.572600E-01
Non Drinker-vs-Daily Drinker
1.565160E-01
Non Drinker-vs-Weekly Drinker
8.617000E-01
Non Drinker-vs-Occasional Drinker
8.435300E-03
Non Drinker-vs-Social Drinker
2.750600E-01
Daily Drinker-vs-Weekly Drinker
2.997400E-01
Daily Drinker-vs-Occasional Drinker
1.119480E-03
Daily Drinker-vs-Social Drinker
4.774500E-02
Weekly Drinker-vs-Occasional Drinker
9.178800E-03
Weekly Drinker-vs-Social Drinker
3.123400E-01
Occasional Drinker-vs-Social Drinker
1.255450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.197580E-01
Normal-vs-Grade 2
1.511760E-02
Normal-vs-Grade 3
1.864060E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.164400E-01
Grade 1-vs-Grade 3
3.446600E-01
Grade 1-vs-Grade 4
1.197580E-01
Grade 2-vs-Grade 3
6.096600E-01
Grade 2-vs-Grade 4
1.511760E-02
Grade 3-vs-Grade 4
1.864060E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.259200E-01
Normal-vs-NonDiabetic
5.271800E-01
Diabetic-vs-NonDiabetic
3.015500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.766600E-01
Normal-vs-NoPancreatitis
5.614200E-01
Pancreatitis-vs-NoPancreatitis
3.707600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.421400E-01
Normal-vs-N1
6.323400E-01
N0-vs-N1
1.108610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.501600E-01
Normal-vs-TP53-NonMutant
5.198600E-01
TP53-Mutant-vs-TP53-NonMutant
9.147400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
